Extramedullary Involvement by Chronic Myelogeneous Leukemia in Five Patients With Unusual Clinicopathologic Features: A Review of the Effectiveness of Tyrosine Kinase Inhibitors

Chronic myelogeneous leukemia (CML) is associated with BCR-ABL1 fusion gene leading to an abnormal tyrosine kinase molecule. The accepted first-line treatment is imatinib mesylate (IM). CML uncommonly occurs in the extramedullary sites at initial presentation or relapse. Here we report five adult pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Abha, Paluri, Ravikumar, Deal, Taylor, Peker, Deniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852783/
https://www.ncbi.nlm.nih.gov/pubmed/27222678
http://dx.doi.org/10.14740/jocmr2566w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852783/
https://www.ncbi.nlm.nih.gov/pubmed/27222678
http://dx.doi.org/10.14740/jocmr2566w

Ejemplares similares